Catherine Brisson
Nessuna posizione attualmente
Storia della carriera di Catherine Brisson
Precedenti posizioni note di Catherine Brisson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Stellar Biotechnologies, Inc.
 Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Direttore operativo | 01/11/2013 | 18/10/2016 |
| Consigliere Generale | 09/08/2012 | 16/08/2012 | |
| Corporate Officer/Principal | 16/08/2012 | 05/11/2013 |
Formazione di Catherine Brisson
| North Carolina State University | Undergraduate Degree |
| The University of North Carolina at Charlotte | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Canada | 2 |
Posizioni
| Chief Operating Officer | 1 |
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |
- Borsa valori
- Insiders
- Catherine Brisson
- Esperienza
